Your browser doesn't support javascript.
loading
Models for Implementing Emergency Department-Initiated Buprenorphine With Referral for Ongoing Medication Treatment at Emergency Department Discharge in Diverse Academic Centers.
Whiteside, Lauren K; D'Onofrio, Gail; Fiellin, David A; Edelman, E Jennifer; Richardson, Lynne; O'Connor, Patrick; Rothman, Richard E; Cowan, Ethan; Lyons, Michael S; Fockele, Callan E; Saheed, Mustapha; Freiermuth, Caroline; Punches, Brittany E; Guo, Clara; Martel, Shara; Owens, Patricia H; Coupet, Edouard; Hawk, Kathryn F.
Afiliação
  • Whiteside LK; Department of Emergency Medicine, University of Washington School of Medicine, Seattle, WA. Electronic address: laurenkw@uw.edu.
  • D'Onofrio G; Department of Emergency Medicine, Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
  • Fiellin DA; Department of Emergency Medicine, Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Center for Interdisciplinary Research on AIDS, Yale School
  • Edelman EJ; Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT.
  • Richardson L; Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
  • O'Connor P; Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
  • Rothman RE; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Cowan E; Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Lyons MS; Department of Emergency Medicine, Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH; Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH.
  • Fockele CE; Department of Emergency Medicine, University of Washington School of Medicine, Seattle, WA.
  • Saheed M; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Freiermuth C; Department of Emergency Medicine, Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH; Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH.
  • Punches BE; Department of Emergency Medicine, Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH; Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH.
  • Guo C; Department of Emergency Medicine, Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
  • Martel S; Department of Emergency Medicine, Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
  • Owens PH; Department of Emergency Medicine, Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
  • Coupet E; Department of Emergency Medicine, Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
  • Hawk KF; Department of Emergency Medicine, Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Program in Addiction Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
Ann Emerg Med ; 80(5): 410-419, 2022 11.
Article em En | MEDLINE | ID: mdl-35752520
ABSTRACT
There has been a substantial rise in the number of publications and training opportunities on the care and treatment of emergency department (ED) patients with opioid use disorder over the past several years. The American College of Emergency Physicians recently published recommendations for providing buprenorphine to patients with opioid use disorder, but barriers to implementing this clinical practice remain. We describe the models for implementing ED-initiated buprenorphine at 4 diverse urban, academic medical centers across the country as part of a federally funded effort termed "Project ED Health." These 4 sites successfully implemented unique ED-initiated buprenorphine programs as part of a comparison of implementation facilitation to traditional educational dissemination on the uptake of ED-initiated buprenorphine. Each site describes the elements central to the ED process, including screening, treatment initiation, referral, and follow-up, while harnessing organizational characteristics, including ED culture. Finally, we discuss common facilitators to program success, including information technology and electronic medical record integration, hospital-level support, strong connections with outpatient partners, and quality improvement processes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article